Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease

10.3390/biomedicines8120589

Saved in:

Bibliographic Details
Main Authors:	Wong, L.R., Wong, P., Ho, P.C.-L.
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	MDPI AG 2021
Subjects:	Alzheimer’s disease Intranasal delivery Metabolic profiling Pioglitazone PLGA nanoparticles
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/196316
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-196316
record_format	dspace
spelling	sg-nus-scholar.10635-1963162024-11-13T22:56:14Z Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease Wong, L.R. Wong, P. Ho, P.C.-L. PHARMACOLOGY PHARMACY Alzheimer’s disease Intranasal delivery Metabolic profiling Pioglitazone PLGA nanoparticles 10.3390/biomedicines8120589 Biomedicines 8 12 1-23 2021-08-10T03:11:41Z 2021-08-10T03:11:41Z 2020 Article Wong, L.R., Wong, P., Ho, P.C.-L. (2020). Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease. Biomedicines 8 (12) : 1-23. ScholarBank@NUS Repository. https://doi.org/10.3390/biomedicines8120589 2227-9059 https://scholarbank.nus.edu.sg/handle/10635/196316 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ MDPI AG Scopus OA2020
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Alzheimer’s disease Intranasal delivery Metabolic profiling Pioglitazone PLGA nanoparticles
spellingShingle	Alzheimer’s disease Intranasal delivery Metabolic profiling Pioglitazone PLGA nanoparticles Wong, L.R. Wong, P. Ho, P.C.-L. Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease
description	10.3390/biomedicines8120589
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY Wong, L.R. Wong, P. Ho, P.C.-L.
format	Article
author	Wong, L.R. Wong, P. Ho, P.C.-L.
author_sort	Wong, L.R.
title	Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease
title_short	Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease
title_full	Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease
title_fullStr	Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease
title_full_unstemmed	Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease
title_sort	metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease
publisher	MDPI AG
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/196316
_version_	1821213221043830784

Metabolic profiling of female tg2576 mouse brains provides novel evidence supporting intranasal low-dose pioglitazone for long-term treatment at an early stage of alzheimer’s disease

Similar Items